Item 1 of 1 (back to results) alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc with beta configuration at the anomeric position of the reducing-end N-acetyl-D-glucosamine residue.

Current search: 03. Biological Effects of Specific Chemicals: epitope [CHEBI:53000] > alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] × Select any link to see items in a related category. more general categories    information about this item 03. Biological Effects of Specific Chemicals  03. Biological Effects of Specific Chemicals  epitope [CHEBI:53000] (470)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1) 08. Chemical Category  08. Chemical Category  main group molecular entity [CHEBI:33579] (25650)   p-block molecular entity [CHEBI:33675] (25343)   chalcogen molecular entity [CHEBI:33304] (15225)   oxygen molecular entity [CHEBI:25806] (14414)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1)  trisaccharide derivative [CHEBI:63571] (187)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1)  organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1)  trisaccharide derivative [CHEBI:63571] (187)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1)  carbon group molecular entity [CHEBI:33582] (23847)   organic molecular entity [CHEBI:50860] (23769)   heteroorganic entity [CHEBI:33285] (15197)   organochalcogen compound [CHEBI:36962] (11874)   organooxygen compound [CHEBI:36963] (11352)   carbohydrate derivative [CHEBI:63299] (2582)   oligosaccharide derivative [CHEBI:63563] (804)   amino oligosaccharide [CHEBI:22483] (607)   glucosamine oligosaccharide [CHEBI:22485] (317)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1)  trisaccharide derivative [CHEBI:63571] (187)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc [CHEBI:52472] (2)   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc [CHEBI:71612] (1) ChEBI Compound Accession Identifier:   [CHEBI:71612] ChEBI Compound Description:   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc with beta configuration at the anomeric position of the reducing-end N-acetyl-D-glucosamine residue. ChEBI Compound Identification Number:   71612 ChEBI InChI Value:   InChI=1S/C25H42N2O19/c1-7(31)26-13-9(33)3-25(24(40)41,45-20(13)15(35)10(34)4-28)46-21-16(36)11(5-29)43-23(18(21)38)44-19-12(6-30)42-22(39)14(17(19)37)27-8(2)32/h9-23,28-30,33-39H,3-6H2,1-2H3,(H,26,31)(H,27,32)(H,40,41)/t9-,10+,11+,12+,13+,14+,15+,16-,17+,18+,19+,20+,21-,22+,23-,25-/m0/s1 ChEBI InChIKey Value:   GVXWGQLSDZJHFY-SDJLXEQRSA-N ChEBI Compound Name:   alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc ChEBI SMILES Value:   [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)[C@@H]1O)C(O)=O)[C@H](O)[C@H](O)CO ChEBI Substance ID:   160713474 ChEBI URL:   ChEBI:71612 ChemSpider ID:   28533682 Ontomatica Chemical Accession Key (OnChAKey):   GVXWGQLSDZJHFY_SDJLXEQRSA_N_000_000000 PubChem Compound ID:   44611401